Abstract Submission now closed
EASL is pleased to invite you to submit abstracts for consideration for Poster Presentation at the upcoming EASL Monothematic Conference: Vascular Liver Diseases to be held in Tallinn, Estonia.
The Conference Programme and Abstract Book will include abstracts of invited lectures and of accepted oral and poster abstracts.
The deadline for submission of abstracts is April 2, 2012. Abstracts received after the deadline will not be accepted.
All accepted abstracts will be in poster format. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
Please note that the abstract content may be edited at the discretion of the Scientific Organising Committee.
Only accepted abstracts of authors who have paid their registration fees by April 25, 2012 will be scheduled for presentation and included in the Programme and Abstract Book.
Guidelines for the submission of abstracts:
Rules for Submission
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
- Only abstracts of authors who have paid their registration fees by April 25, 2012 will be scheduled for presentation and included in the Programme and Abstract Book.
- The Scientific Organising Committee will review abstracts and information regarding acceptance, and scheduling will be sent to the correspondence contact by e-mail only (N.B. The presenting author will receive notification if they are also listed as the correspondence contact). If you have not received notification by mid-April 2012, please contact the Secretariat at firstname.lastname@example.org and be sure to check your spam folder.
- Abstract submitters are required to complete the Conflict of Interest Declaration when submitting their abstract. (If accepted for oral presentation, a link to the official EASL Disclosure Policy will be sent via email and the completion and return of this form is mandatory).
- It is mandatory that all oral presenters prepare a disclosure slide as the first slide in their presentation. If presenters have nothing to disclose, this slide must be included indicated “nothing to disclose”).
Guidelines for Submission of Abstracts
Before you begin, please prepare the following information:
Abstract title – must be in UPPER CASE and is limited to 25 words.
Tables or graphs which you wish to include in the abstract. Images should be submitted in JPG/BMP format, maximum width 9cm, and resolution up to 150dpi. Please note that these may be resized to fit in the final printed material.
Abstract text – limited to 300 words including acknowledgements (fewer if a figure is included in the abstract).
- Presenting author's contact details; include full mailing address, office hours, phone number, email address and fax number.
- Author or authors' names: first name(s) family name (e.g. J.C. Smith).
- Affiliation details of all authors: Department; Institution / Hospital; City; State/Province (if relevant); Country.
- Presentation type:
(Please note that consideration will be given to your preferred presentation type, however the final allocation will be determined by the reviewing committee)
Abstracts should be as informative as possible and must use the following structured format:
Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
Use generic names of drugs. Express numbers as numerals.
Please do not include keywords as they will be removed from publication.
- Background and aims
- Conclusions (avoid evasive statements like "the findings will be discussed").
We recommend using word-processing software (for example Word) for editing your abstract and counting the number of words. Typing your text directly into the field is not recommended. You will receive an abstract reference number via e-mail after you have submitted your abstract.
You will not receive a copy of your abstract so please save your abstract accordingly for your records.
If you are unable to submit abstracts via the website, please contact the Secretariat at email@example.com
ABSTRACTS SUBMITTED BY FAX OR E-MAIL WILL NOT BE ACCEPTED